Seattle biotech BrainChild Bio has raised $116 million to advance an experimental CAR T cell therapy for DIPG, a rare and ...

Five-year-old Finley Domy is bravely facing a DIPG diagnosis, and his devoted parents are quitting their jobs to cherish ...

A researcher at the University of Wisconsin-Madison is working on developing treatments for the rare and deadly brain cancer ...

ILLUMINATE Phase 2 pivotal study will enroll patients at six leading pediatric oncology centers across the U.S.B7-H3-targeted autologous CAR T ...

Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after ...

Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of ...

BrainChild Bio’s lead asset BCB-276 is in pivotal development for diffuse intrinsic pontine glioma, a rare and fatal brain tumor that affects around 300 children in the U.S. every year.

TORONTO, May 17, 2025 (GLOBE NEWSWIRE) -- Today, on DIPG Awareness Day, Brain Cancer Canada is pleased to award $68,000 for an innovative research initiative led by Dr. Aru Narendran, MD, PhD, and Dr.

DIPG Alliance to raise S$5 M over five years to establish Singapore's first enduring paediatric brain tumour research fund ...